| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
| Targets |
NS2B/NS3-IN-3 hydrochloride targets the Flavivirus NS2B-NS3 protease, a serine protease essential for viral polyprotein processing and replication. It binds the active site of the protease and inhibits its catalytic activity, preventing cleavage of the viral polyprotein into functional proteins. This blocks viral replication. It is active against Zika, dengue, and West Nile virus proteases.
|
|---|---|
| ln Vitro |
NS2B/NS3-IN-3 hydrochloride (Compd 66): with an EC68 value of 1-3 μM, it has potent antiviral activity against Zika virus cellular reproduction in cells.
In vitro, NS2B/NS3-IN-3 hydrochloride inhibits Zika virus NS2B-NS3 protease with an IC50 of 0.32 µM. It also inhibits dengue virus type 2 and West Nile virus NS2B-NS3 proteases. It exhibits strong antiviral activity against cellular replication of Zika virus in cells with EC68 values of 1-3 µM. It shows low cytotoxicity. |
| ln Vivo |
No independent in vivo efficacy data are available for NS2B/NS3-IN-3 hydrochloride. As a research compound, it is primarily used for in vitro and cellular studies. In vivo characterization, including pharmacokinetics, efficacy, and toxicity, has not been reported in published literature. Its therapeutic potential in animal models remains to be determined.
|
| Enzyme Assay |
For non-cell enzyme assays, recombinant Flavivirus NS2B-NS3 protease is incubated with NS2B/NS3-IN-3 hydrochloride and a fluorogenic peptide substrate. Protease activity is measured by fluorescence release. IC50 values are calculated from dose-response curves. Selectivity is assessed against other viral and human proteases.
|
| Cell Assay |
In cell assays, Vero cells or other permissive cells are infected with Zika virus, dengue virus, or West Nile virus in the presence of NS2B/NS3-IN-3 hydrochloride. Viral replication is measured by plaque assay, qPCR, or immunofluorescence. EC50 values are calculated. Cell viability is measured by MTT.
|
| Animal Protocol |
No established in vivo animal protocol exists for NS2B/NS3-IN-3 hydrochloride. If in vivo studies were conducted, the compound would be formulated in DMSO/PEG/saline or saline and administered intraperitoneally or orally in mice infected with Zika virus or dengue virus. Survival, viral load, and clinical signs would be monitored. Pharmacokinetics would be determined by LC-MS.
|
| References |
| Molecular Formula |
C19H22CLN3O2
|
|---|---|
| Molecular Weight |
359.849883556366
|
| Exact Mass |
359.14
|
| CAS # |
2832876-91-0
|
| Related CAS # |
NS2B/NS3-IN-3;2832876-90-9
|
| PubChem CID |
169450567
|
| Appearance |
Orange to red solid powder
|
| tPSA |
70.1
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
25
|
| Complexity |
438
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C1CNCCC1CNC(=O)C2=CC3=C(N2)C=C(C=C3)C4=COC=C4.Cl
|
| InChi Key |
ILKRKFAPUXCGDZ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C19H21N3O2.ClH/c23-19(21-11-13-3-6-20-7-4-13)18-10-15-2-1-14(9-17(15)22-18)16-5-8-24-12-16;/h1-2,5,8-10,12-13,20,22H,3-4,6-7,11H2,(H,21,23);1H
|
| Chemical Name |
6-(furan-3-yl)-N-(piperidin-4-ylmethyl)-1H-indole-2-carboxamide;hydrochloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage. (2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~10 mg/mL (~27.79 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1 mg/mL (2.78 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1 mg/mL (2.78 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7789 mL | 13.8947 mL | 27.7894 mL | |
| 5 mM | 0.5558 mL | 2.7789 mL | 5.5579 mL | |
| 10 mM | 0.2779 mL | 1.3895 mL | 2.7789 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.